| 1 | Acthar high dose (80 U) | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬
| [1] MC2R MC2R 💬
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 49 49 💬
|
| 2 | Administration of a high dose of desipramine | [1] Desipramine Desipramine | [1] Desipramine
Desipramine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 156 156 💬
|
| 3 | Ambrisentan - high dose | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 4 | AXO-AAV-GM2 High Dose | - | - | - | - | [1] 19 19 💬
|
| 5 | BI 655064 high dose | - | - | - | - | [1] 46 46 💬
|
| 6 | BIIL 284 BS high dose | - | - | - | - | [1] 46 46 💬
|
| 7 | BIIL 284 BS, high dose | - | - | - | - | [1] 299 299 💬
|
| 8 | BIIL 284 BS, high dose, adult patients | - | - | - | - | [1] 299 299 💬
|
| 9 | BIIL 284 BS, high dose, pediatric patients | - | - | - | - | [1] 299 299 💬
|
| 10 | BIRB 796 BS, high dose | - | - | - | - | [1] 46 46 💬
|
| 11 | BLI-1300 high dose | - | - | - | - | [1] 96 96 💬
|
| 12 | Brazikumab high dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 13 | CHF10067 high dose | - | - | - | - | [1] 85 85 💬
|
| 14 | Clobazam High Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 15 | CPL500036 - high dose | - | - | - | - | [1] 6 6 💬
|
| 16 | CVT-301 High Dose | - | - | - | - | [1] 6 6 💬
|
| 17 | DNS-7801 (high dose) | - | - | - | - | [1] 6 6 💬
|
| 18 | Elamipretide (high dose) | [1] Elamipretide Elamipretide | [1] Elamipretide
Elamipretide
💬
| - | - | [1] 21 21 💬
|
| 19 | Enpatoran high dose | - | - | - | - | [1] 49 49 💬
|
| 20 | EUR-1008 (APT-1008) High Dose | - | - | - | - | [1] 298 298 💬
|
| 21 | Fentanyl (High Dose) | [1] Fentanyl Fentanyl | [1] Fentanyl
Fentanyl
💬
| [1] OPRM1 OPRM1 💬
| [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 215 215 💬
|
| 22 | GTX-102 high dose fast Period 1 and Period 2 | [1] GTX-102 GTX-102 | - | - | - | [1] 65 65 💬
|
| 23 | High dose | - | - | - | - | [1] 97 97 💬
|
| 24 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | [1] 6 6 💬
|
| 25 | High dose ANAVEX2-73 | - | - | - | - | [1] 6 6 💬
|
| 26 | High Dose Aspirin (1300 mg/day) | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 💬
|
| 27 | High dose BIBF 1120 twice daily | - | - | - | - | [1] 85 85 💬
|
| 28 | High Dose Budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 29 | High dose budesonide suspension | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 30 | High dose budesonide tablet | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 31 | High dose Dexamethasone pulses | [1] Dexamethasone Dexamethasone | [1] Dexamethasone
Dexamethasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 32 | High dose lactulose | [1] Lactulose Lactulose | [1] Lactulose
Lactulose
💬
| - | - | [1] 291 291 💬
|
| 33 | High dose levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 34 | High Dose LX2006 | - | - | - | - | [1] 18 18 💬
|
| 35 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 💬
|
| 36 | High Dose MT-1303 | - | - | - | - | [1] 97 97 💬
|
| 37 | High Dose MYOBLOC | [1] Botulinum toxin type B Botulinum toxin type B | [1] Rimabotulinumtoxin B
Rimabotulinumtoxin B
💬
| [1] SNAP25 SNAP25 💬
| [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 38 | High dose of BIIL 284 BS tablets | - | - | - | - | [1] 46 46 💬
|
| 39 | High dose of budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 40 | High dose ORTD-1 | - | - | - | - | [1] 46 46 💬
|
| 41 | High dose TSO | - | - | - | - | [1] 96 96 💬
|
| 42 | High dose vehicle control | - | - | - | - | [1] 46 46 💬
|
| 43 | High Dose-VIS649 | - | - | - | - | [1] 66 66 💬
|
| 44 | High doses of Thiamine y Biotin | [2] Biotin Biotin, Thiamine | [2] Biotin
Biotin
,
Thiamine
💬
| - | - | [1] 8 8 💬
|
| 45 | HMPL-004 high dose | - | - | - | - | [1] 97 97 💬
|
| 46 | IgPro20 (high dose) | - | - | - | - | [1] 14 14 💬
|
| 47 | Imsidolimab high dose | [1] Imsidolimab Imsidolimab | [1] Imsidolimab
Imsidolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 37 37 💬
|
| 48 | KPS-0373, High dose | - | - | - | - | [1] 18 18 💬
|
| 49 | KW-6356 High Dose | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 50 | LiRIS low dose and LiRIS high dose | - | - | - | - | [1] 226 226 💬
|
| 51 | LX3305 high dose | - | - | - | - | [1] 46 46 💬
|
| 52 | M5049 high dose | - | - | - | - | [2] 49 49, 50 💬
|
| 53 | MEDI7183 high dose | - | - | - | - | [1] 97 97 💬
|
| 54 | MMX Mesalamine/Mesalazine (High Dose) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 55 | MT-1303 High dose | - | - | - | - | [1] 49 49 💬
|
| 56 | MT-7117 High Dose | - | - | - | - | [1] 254 254 💬
|
| 57 | MultiStem high dose | [1] MultiStem MultiStem | - | - | - | [1] 97 97 💬
|
| 58 | OCU400 High Dose | - | - | - | - | [1] 90 90 💬
|
| 59 | Orelabrutinib (High Dose) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 49 49 💬
|
| 60 | Part 2 Adult Alogabat High Dose (aged 15-17) | - | - | - | - | [1] 201 201 💬
|
| 61 | PF-06649751 high dose (15 mg QD) | [1] Tavapadon Tavapadon | [1] Tavapadon
Tavapadon
💬
| [2] DRD1 DRD1, DRD5 💬
| [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 62 | PHA-022121 high dose | - | - | - | - | [1] 65 65 💬
|
| 63 | PXT3003 High Dose | - | - | - | - | [1] 10 10 💬
|
| 64 | Ravicti high dose | [1] Glycerol phenylbutyrate Glycerol phenylbutyrate | [1] Glycerol phenylbutyrate
Glycerol phenylbutyrate
💬
| - | - | [1] 299 299 💬
|
| 65 | SA001 High dose | - | - | - | - | [1] 53 53 💬
|
| 66 | SC0062 high dose | - | - | - | - | [1] 66 66 💬
|
| 67 | SEN0014196 (High Dose) | - | - | - | - | [1] 8 8 💬
|
| 68 | TAS5315 high dose | - | - | - | - | [1] 46 46 💬
|
| 69 | Vitamin D3 - high dose | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 6 6 💬
|
| 70 | YRA-1909 high dose | - | - | - | - | [1] 46 46 💬
|